search
Back to results

Comparison of Infraclavicular And Supraclavicular Block

Primary Purpose

Anesthesia Conduction, Upper Extremity Surgery, Pain, Postoperative

Status
Unknown status
Phase
Phase 4
Locations
Turkey
Study Type
Interventional
Intervention
Bupivacaine HCl 0.5% Injectable Solution
Prilocaine HCl 2% Injectable solution
Adrenaline amp. 0.5 mg
Ultrasound guided supraclavicular block with coronal oblique method
Ultrasound guided lateral sagittal infraclavicular block
Sponsored by
Bozyaka Training and Research Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anesthesia Conduction focused on measuring Brachial plexus block, Nerve block

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 18-65 years old
  • ASA I-II
  • Patients scheduled for hand, wrist, and forearm surgery

Exclusion Criteria:

  • Uncoordinated patients
  • Having a disease that prevents sensory block evaluation,
  • Have coagulopathy,
  • Known allergies to drugs to be used,
  • Those with anatomical disorders at the application points
  • Pregnant patients,
  • Patients under 18 years of age,
  • Patients with known local anesthetic allergy,
  • Patients diagnosed with sepsis and bacteriemia,
  • Skin infection at the injection site.

Sites / Locations

  • Izmir Bozyaka Training and Research Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Supraclaviculer block

Infraclaviculer block

Arm Description

The coronal oblique supraclavicular block will be applied to the first group with ultrasound guidance using a 22G 50 mm stimulator needle. 30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml. (14 ml. bupivacaine, 14 ml. prilocaine, 2 ml saline with 5 mcg adrenaline per ml.) Intermittent negative aspiration will be performed during all procedures to detect possible vascular puncture.

The lateral sagittal infraclavicular block will be applied to the second group with ultrasound guidance using a 22G 100 mm stimulator needle. 30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml. (14 ml. bupivacaine, 14 ml. prilocaine, 2 ml saline with 5 mcg adrenaline per ml.). Intermittent negative aspiration will be performed during all procedures to detect possible vascular puncture.

Outcomes

Primary Outcome Measures

Block Formation Time
Block formation time will be defined as the time required to initiate anesthesia and analgesia in all 5 distal nerves.
Block Application Time
Block application time will be defined as the time from the moment the needle passes the skin until the local anesthetic is given and withdrawn.
Block success
Block success; at the 30th minute of local anesthesic application, the pinprick test will define the presence of insensibility or only a sense of touch in the musculocutaneous, radial, ulnar, median, cutaneous antebrachii nerves. If any of these nerves are not blocked, it will be considered a failed block.
Sensory Block Level 5th minute
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
Sensory Block Level 10th minute
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
Sensory Block Level 15th minute
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
Sensory Block Level 20th minute
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
Sensory Block Level 25th minute
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
Sensory Block Level 30th minute
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).

Secondary Outcome Measures

The Motor Block Level 10th minute
The motor block will be evaluated with a Modified Bromage Scale. ( 0: No blocks, he can lift his arm; 1: Arm is weak but active; 2: Arm is motionless but fingers are active; 3: Complete block, no movement in hand or arm. )
Postoperative Analgesia Time
Postoperative analgesia time; It will be considered as when the NRS (Numeric Rating Scale) is≥1.
Pain Score Follow-up 2nd Hour
Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS (Numeric Rating Scale) scores at the 2nd hour.
Block Return Time
Sensory (the time from local anaesthetic injection until the patient fully perceives the upper limb) and motor (the time from local anaesthetic injection until the patient's upper extremity regains full muscle strength) block time will be recorded as the block return time.
Patient and Surgeon Satisfaction
Patient and surgeon satisfaction will be evaluated as 1 = complete dissatisfaction, 2 = moderate dissatisfaction, 3 = moderate satisfaction 4 =full satisfaction, after the procedure.
Undesirable Side Effects
Patients will be followed up for 24 hours in terms of undesirable side effects, vascular puncture, hematoma, signs of LA toxicity, respiratory distress, pneumothorax, and horner syndrome.
The Rescue Analgesia
As rescue analgesia, Tramadol 1 mg/kg IV will be ordered to be administered when the patient's NRS is 3 or more. The first time when the patient receives rescue analgesia will be recorded.
24-Hour Total Opioid Consumption
The total dose of rescue analgesia (Tramadol ) for the first 24 hours will be recorded.
Pain Score Follow-up 6th Hour
Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS (Numeric Rating Scale) scores at the 6th hour.
Pain Score Follow-up 12th Hour
Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS (Numeric Rating Scale) scores at the 12th hour.
Pain Score Follow-up 24th Hour
Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS (Numeric Rating Scale) scores at the 24th hour.
The Motor Block Level 20th minute
The motor block will be evaluated with a Modified Bromage Scale. ( 0: No blocks, he can lift his arm; 1: Arm is weak but active; 2: Arm is motionless but fingers are active; 3: Complete block, no movement in hand or arm. )
The Motor Block Level 30th minute
The motor block will be evaluated with a Modified Bromage Scale. ( 0: No blocks, he can lift his arm; 1: Arm is weak but active; 2: Arm is motionless but fingers are active; 3: Complete block, no movement in hand or arm. )

Full Information

First Posted
March 2, 2021
Last Updated
March 2, 2021
Sponsor
Bozyaka Training and Research Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04784104
Brief Title
Comparison of Infraclavicular And Supraclavicular Block
Official Title
Comparison of Infraclavicular and Supraclavicular Block Approaches in Ultrasound Guided Brachial Plexus Block
Study Type
Interventional

2. Study Status

Record Verification Date
March 2021
Overall Recruitment Status
Unknown status
Study Start Date
March 5, 2021 (Anticipated)
Primary Completion Date
August 15, 2021 (Anticipated)
Study Completion Date
September 1, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Bozyaka Training and Research Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Ultrasound-guided brachial plexus blocks are used successfully for upper extremity surgeries. In this randomized prospective single-blind study, ASA I-II patients aged 18-65 years undergoing hand, wrist, and forearm surgery will be randomly divided into two groups. First group will receive ultrasound-guided coronal oblique supraclavicular block using a 22G, 50 mm stimulator needle, and the second group, ultrasound-guided lateral sagittal infraclavicular block using a 22G 100 mm stimulator needle. We will prepare, 30 ml of 1:1 0.5% bupivacaine and 2% prilocaine with 5 mcg adrenaline per milliliter as local anesthetic mixture. Block application time, block success, sensory and motor block levels, and postoperative analgesia time will be recorded and compared between the groups. Accordingly, the success rate of the two methods will be evaluated.
Detailed Description
In this prospective single-blind study, patients will be divided into 2 groups with the closed envelope method. Patients will be taken to the block application room before the operation. Standard monitoring (pulse oximetry, noninvasive blood pressure, ECG) will be applied to the patients. Premedication will be provided with 1mg IV midazolam after peripheral vascular access. Blocks will be performed by an experienced anesthesiologist under the guidance of USG and evaluated by another anesthesiologist who is blind to the block technique. After the antisepsis of the area, a 22G 100 mm stimulator needle will be used in the infraclavicular approach and a 22G 50 mm in the supraclavicular block. Intermittent negative aspiration will be performed during all procedures to detect possible vascular puncture. 30 ml of 1:1 0.5% bupivacaine and 2% prilocaine plus 5 mcg adrenaline per ml will be used as local anesthetic mixture. The infraclavicular block will be applied by the lateral sagittal method under USG guidance. Supraclavicular block will be applied in the coronal oblique plane while the probe is placed on the clavicle. Following the blocks, the 5th, 10th, 15th, 20th, 25th, and 30th-minute sensory block levels, 10th, 20th, and 30th-minute motor block levels will be recorded. Sensory block level; Axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain). The motor block will be evaluated with a modified bromage scale: 0: No blocks, he can lift his arm; 1: Arm is weak but active; 2: Arm is motionless but fingers are active; 3: Complete block, no movement in hand or arm. Block success; At the 30th minute of LA application, the pinprick test will define the presence of insensibility or only a sense of touch in the musculocutaneous, radial, ulnar, median, cutaneous antebrachii nerves. If any of these nerves are not blocked, it will be considered a failed block. Postoperative analgesia time; It will be considered as when the NRS(Numeric Rating Scale) is≥1. Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS scores at the 2nd, 6th, 12th, 24th hours. Sensory (the time from local anesthetic injection until the patient fully perceives the upper limb) and motor (the time from local anesthetic injection until the patient's upper extremity regains full muscle strength) block time will be recorded as the block return time. Pain score during block application will be evaluated with the NRS. Block application time will be defined as the time from the moment the needle passes the skin until the local anesthetic is given and withdrawn. Block formation time will be defined as the time required to initiate anesthesia and analgesia in all 5 distal nerves. Patient and surgeon satisfaction will be evaluated as 1 = complete dissatisfaction, 2 = moderate satisfaction, 3 = full satisfaction, after the procedure. Patients will be followed up for 24 hours in terms of undesirable side effects, vascular puncture, hematoma, signs of LA toxicity, respiratory distress, pneumothorax, and horner syndrome. As rescue anesthesia, sedoanalgesia will be tried with remifentanil infusion, if it is not successful, general anesthesia will be started with a laryngeal mask. As postoperative analgesic regimen, patients will receive 3 x 1000 mg IV acetaminophen. As rescue analgesia, Tramadol 1 mg/kg IV will be ordered to be administered when the patient's NRS is 3 or more. The first time when the patient receives rescue analgesia and the total dose of rescue analgesia for the first 24 hours will be recorded.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anesthesia Conduction, Upper Extremity Surgery, Pain, Postoperative, Anesthesia and Analgesia, Nerve Block, Brachial Plexus Block
Keywords
Brachial plexus block, Nerve block

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
The study covers 2 groups. Supraclavicular block will be applied to the first group and infraclavicular block will be applied to the second group.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
70 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Supraclaviculer block
Arm Type
Experimental
Arm Description
The coronal oblique supraclavicular block will be applied to the first group with ultrasound guidance using a 22G 50 mm stimulator needle. 30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml. (14 ml. bupivacaine, 14 ml. prilocaine, 2 ml saline with 5 mcg adrenaline per ml.) Intermittent negative aspiration will be performed during all procedures to detect possible vascular puncture.
Arm Title
Infraclaviculer block
Arm Type
Experimental
Arm Description
The lateral sagittal infraclavicular block will be applied to the second group with ultrasound guidance using a 22G 100 mm stimulator needle. 30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml. (14 ml. bupivacaine, 14 ml. prilocaine, 2 ml saline with 5 mcg adrenaline per ml.). Intermittent negative aspiration will be performed during all procedures to detect possible vascular puncture.
Intervention Type
Drug
Intervention Name(s)
Bupivacaine HCl 0.5% Injectable Solution
Other Intervention Name(s)
Bupivacaine 0.5%
Intervention Description
30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml. (14 ml. bupivacaine, 14 ml. prilocaine and 2 ml saline with 5 mcg adrenaline per ml.)
Intervention Type
Drug
Intervention Name(s)
Prilocaine HCl 2% Injectable solution
Other Intervention Name(s)
Priloc %2
Intervention Description
30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml. (14 ml. bupivacaine, 14 ml. prilocaine and 2 ml saline with 5 mcg adrenaline per ml.)
Intervention Type
Drug
Intervention Name(s)
Adrenaline amp. 0.5 mg
Other Intervention Name(s)
Adrenalin codex 0.5 mg 1 ml injectable solution
Intervention Description
30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml. (14 ml. bupivacaine, 14 ml. prilocaine and 2 ml saline with 5 mcg adrenaline per ml.)
Intervention Type
Procedure
Intervention Name(s)
Ultrasound guided supraclavicular block with coronal oblique method
Intervention Description
The blocks will be performed by an experienced anesthesiologist with a USG guidence.
Intervention Type
Procedure
Intervention Name(s)
Ultrasound guided lateral sagittal infraclavicular block
Intervention Description
The blocks will be performed by an experienced anesthesiologist with USG guidence.
Primary Outcome Measure Information:
Title
Block Formation Time
Description
Block formation time will be defined as the time required to initiate anesthesia and analgesia in all 5 distal nerves.
Time Frame
30th minute pre-operatively
Title
Block Application Time
Description
Block application time will be defined as the time from the moment the needle passes the skin until the local anesthetic is given and withdrawn.
Time Frame
During Block Application
Title
Block success
Description
Block success; at the 30th minute of local anesthesic application, the pinprick test will define the presence of insensibility or only a sense of touch in the musculocutaneous, radial, ulnar, median, cutaneous antebrachii nerves. If any of these nerves are not blocked, it will be considered a failed block.
Time Frame
At the 30th minute of LA application
Title
Sensory Block Level 5th minute
Description
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
Time Frame
5th minute
Title
Sensory Block Level 10th minute
Description
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
Time Frame
10th minute
Title
Sensory Block Level 15th minute
Description
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
Time Frame
15th minute
Title
Sensory Block Level 20th minute
Description
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
Time Frame
20th minute
Title
Sensory Block Level 25th minute
Description
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
Time Frame
25th minute
Title
Sensory Block Level 30th minute
Description
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
Time Frame
30th minute
Secondary Outcome Measure Information:
Title
The Motor Block Level 10th minute
Description
The motor block will be evaluated with a Modified Bromage Scale. ( 0: No blocks, he can lift his arm; 1: Arm is weak but active; 2: Arm is motionless but fingers are active; 3: Complete block, no movement in hand or arm. )
Time Frame
10th minute
Title
Postoperative Analgesia Time
Description
Postoperative analgesia time; It will be considered as when the NRS (Numeric Rating Scale) is≥1.
Time Frame
24 hours post-operatively
Title
Pain Score Follow-up 2nd Hour
Description
Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS (Numeric Rating Scale) scores at the 2nd hour.
Time Frame
2nd hour
Title
Block Return Time
Description
Sensory (the time from local anaesthetic injection until the patient fully perceives the upper limb) and motor (the time from local anaesthetic injection until the patient's upper extremity regains full muscle strength) block time will be recorded as the block return time.
Time Frame
24 hours postoperatively
Title
Patient and Surgeon Satisfaction
Description
Patient and surgeon satisfaction will be evaluated as 1 = complete dissatisfaction, 2 = moderate dissatisfaction, 3 = moderate satisfaction 4 =full satisfaction, after the procedure.
Time Frame
Immediately after the surgery
Title
Undesirable Side Effects
Description
Patients will be followed up for 24 hours in terms of undesirable side effects, vascular puncture, hematoma, signs of LA toxicity, respiratory distress, pneumothorax, and horner syndrome.
Time Frame
24 hours postoperatively
Title
The Rescue Analgesia
Description
As rescue analgesia, Tramadol 1 mg/kg IV will be ordered to be administered when the patient's NRS is 3 or more. The first time when the patient receives rescue analgesia will be recorded.
Time Frame
24 hours postoperatively
Title
24-Hour Total Opioid Consumption
Description
The total dose of rescue analgesia (Tramadol ) for the first 24 hours will be recorded.
Time Frame
24 hours postoperatively
Title
Pain Score Follow-up 6th Hour
Description
Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS (Numeric Rating Scale) scores at the 6th hour.
Time Frame
6th Hour
Title
Pain Score Follow-up 12th Hour
Description
Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS (Numeric Rating Scale) scores at the 12th hour.
Time Frame
12th Hour
Title
Pain Score Follow-up 24th Hour
Description
Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS (Numeric Rating Scale) scores at the 24th hour.
Time Frame
24th Hour
Title
The Motor Block Level 20th minute
Description
The motor block will be evaluated with a Modified Bromage Scale. ( 0: No blocks, he can lift his arm; 1: Arm is weak but active; 2: Arm is motionless but fingers are active; 3: Complete block, no movement in hand or arm. )
Time Frame
20th minute
Title
The Motor Block Level 30th minute
Description
The motor block will be evaluated with a Modified Bromage Scale. ( 0: No blocks, he can lift his arm; 1: Arm is weak but active; 2: Arm is motionless but fingers are active; 3: Complete block, no movement in hand or arm. )
Time Frame
30th minute

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18-65 years old ASA I-II Patients scheduled for hand, wrist, and forearm surgery Exclusion Criteria: Uncoordinated patients Having a disease that prevents sensory block evaluation, Have coagulopathy, Known allergies to drugs to be used, Those with anatomical disorders at the application points Pregnant patients, Patients under 18 years of age, Patients with known local anesthetic allergy, Patients diagnosed with sepsis and bacteriemia, Skin infection at the injection site.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mehmet E Şen, MD
Phone
+905436838272
Email
m_emre_sen@hotmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Zeki T Tekgül, Assoc Prof
Phone
+905058554705
Email
zekitekgul@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mehmet E Şen, MD
Organizational Affiliation
Izmir Bozyaka Training and Research Hospital
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Zeki T Tekgül, Assoc Prof
Organizational Affiliation
Izmir Bozyaka Training and Research Hospital
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Taşkın Altay, Assoc Prof
Organizational Affiliation
Izmir Bozyaka Training and Research Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Izmir Bozyaka Training and Research Hospital
City
Izmir
State/Province
Karabağlar
ZIP/Postal Code
35170
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23364778
Citation
Gurkan Y, Hosten T, Tekin M, Acar S, Solak M, Toker K. [Comparison of ultrasound-guided supraclavicular and infraclavicular approaches for brachial plexus blockade]. Agri. 2012;24(4):159-64. doi: 10.5505/agri.2012.38247. Turkish.
Results Reference
background
PubMed Identifier
30857608
Citation
Grape S, Pawa A, Weber E, Albrecht E. Retroclavicular vs supraclavicular brachial plexus block for distal upper limb surgery: a randomised, controlled, single-blinded trial. Br J Anaesth. 2019 Apr;122(4):518-524. doi: 10.1016/j.bja.2018.12.022. Epub 2019 Jan 31.
Results Reference
background
PubMed Identifier
16116009
Citation
Arcand G, Williams SR, Chouinard P, Boudreault D, Harris P, Ruel M, Girard F. Ultrasound-guided infraclavicular versus supraclavicular block. Anesth Analg. 2005 Sep;101(3):886-890. doi: 10.1213/01.ANE.0000159168.69934.CC.
Results Reference
background

Learn more about this trial

Comparison of Infraclavicular And Supraclavicular Block

We'll reach out to this number within 24 hrs